CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $146,828,000 | +0.3% | 1,240,000 | 0.0% | 0.58% | -8.6% |
| Q4 2020 | $146,456,000 | +6.3% | 1,240,000 | 0.0% | 0.63% | -10.1% |
| Q3 2020 | $137,814,000 | +8.8% | 1,240,000 | 0.0% | 0.70% | -7.4% |
| Q2 2020 | $126,703,000 | +18.6% | 1,240,000 | +25.3% | 0.76% | -4.1% |
| Q1 2020 | $106,851,000 | -7.3% | 990,000 | 0.0% | 0.79% | +4.6% |
| Q4 2019 | $115,216,000 | +1.7% | 990,000 | 0.0% | 0.75% | -9.3% |
| Q3 2019 | $113,325,000 | +20.1% | 990,000 | 0.0% | 0.83% | +23.1% |
| Q2 2019 | $94,347,000 | +4.4% | 990,000 | 0.0% | 0.67% | +7.8% |
| Q1 2019 | $90,338,000 | +20.2% | 990,000 | 0.0% | 0.62% | +20.9% |
| Q4 2018 | $75,151,000 | -5.1% | 990,000 | 0.0% | 0.52% | +12.1% |
| Q3 2018 | $79,200,000 | -19.5% | 990,000 | 0.0% | 0.46% | -10.8% |
| Q2 2018 | $98,337,000 | +22.6% | 990,000 | 0.0% | 0.52% | +17.5% |
| Q1 2018 | $80,190,000 | +2.8% | 990,000 | 0.0% | 0.44% | -8.1% |
| Q4 2017 | $77,982,000 | +2184.2% | 990,000 | +2576.0% | 0.48% | +2295.0% |
| Q3 2017 | $3,414,000 | – | 36,995 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 131,657 | $13,077,000 | 5.92% |
| Point72 Hong Kong Ltd | 103,797 | $10,310,000 | 3.49% |
| York Capital Management Global Advisors, LLC | 827,738 | $82,219,000 | 2.00% |
| Parametrica Management Ltd | 3,889 | $386,000 | 1.83% |
| Athos Capital Ltd | 35,266 | $3,503,000 | 1.19% |
| Hillhouse Capital Management | 618,391 | $61,425,000 | 1.05% |
| JUPITER ASSET MANAGEMENT LTD | 502,812 | $49,940,000 | 0.73% |
| Black Creek Investment Management Inc. | 240,232 | $23,862,000 | 0.73% |
| COMGEST GLOBAL INVESTORS S.A.S. | 243,652 | $24,202,000 | 0.54% |
| Temasek Holdings (Private) Ltd | 990,000 | $98,337,000 | 0.52% |